The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India

Prabodh Malhotra

DOI: 10.20529/IJME.2008.023


Currently, there is a debate on what impact the implementation of the Trade Related Aspects of Intellectual Property Rights (TRIPS) in India would have on its pharmaceutical industry and health care. The debate hinges primarily on two major questions. First, will the new patent regime provide an impetus for innovation in the pharmaceutical industry? Second, how far will India’s pharmaceutical exports of copied versions of patented drugs to developing countries be restricted under the new regime? The first question seeks to find out if TRIPS will increase India’s innovative capabilities to fill the current vacuum to develop drugs for tropical diseases.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US